Table 1.
Contains a group of proteins that have been identified as potential biomarkers when combined. The columns represent the cancer type, the protein marker panel, the analytical technique that were used for the analysis and the reference number in the review.
| Cancer type | Panel of protein markers | Technique | Reference no. |
|---|---|---|---|
| Lung | carcinoembryonic antigen, retinol binding protein alpha 1-antitrypsin squamous cell carcinoma antigen |
2D-DIGE and MALDI-TOF | 55 |
| Ovarian | Corticosteroid-binding globulin (CBG) serum amyloid p component (SAP) complement factor B (CFAB) |
lectin array and quantitative LC-MS/MS |
59 |
| Head and neck | 14-3-3 protein zeta/delta (YWHAZ), stratifin S100-A7 |
Multidimensional LC-MS/MS | 54 |
| Pancreatic Cancer | α-1-antichymotrypsin (AACT) thrombospondin-1 (THBS1) haptoglobin (HPT) |
Label-free and TMT strategies LC-MS/MS |
67 |